摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-羟基萘-2-羧酸乙酯 | 84701-39-3

中文名称
7-羟基萘-2-羧酸乙酯
中文别名
——
英文名称
7-Hydroxy-2-naphthoesaeure-ethylester
英文别名
7-hydroxynaphthalene-2-carboxylic acid ethyl ester;ethyl 7-hydroxynaphthalene-2-carboxylate
7-羟基萘-2-羧酸乙酯化学式
CAS
84701-39-3
化学式
C13H12O3
mdl
——
分子量
216.236
InChiKey
PXWZTMTYCLZOCT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Ruthenium-Catalyzed Cross-Selective Asymmetric Oxidative Coupling of Arenols
    作者:Hiroki Hayashi、Takamasa Ueno、Chungsik Kim、Tatsuya Uchida
    DOI:10.1021/acs.orglett.0c00048
    日期:2020.2.21
    (Aqua)ruthenium(salen) complex 1c achieved good to high chemo- and enantioselective oxidative cross-coupling of arenols. The catalytic system can be used to selectively produce C1-symmetric bis(arenol)s from the combination of C3- and C7-substituted 2-naphthols or phenols even when there is no significant difference in oxidation potential between the cross-coupling partners. This unique cross-selectivity
    (salen)配合物1c实现了良好的芳烃化学-对映选择性氧化交叉偶联。该催化体系可用于从C3和C7取代的2-萘酚苯酚的组合中选择性地生产C1对称的双(芳烯醇),即使在交叉偶联配偶体之间的氧化电位没有显着差异时。这种独特的交叉选择性受空间的影响而不是芳烃的电子作用,并且可以通过化学选择性单电子氧化和氧化碳-碳键形成来控制。
  • Compounds
    申请人:Fisons Limited
    公开号:US04424231A1
    公开(公告)日:1984-01-03
    There are described compounds of formula I, ##STR1## in which Ra, Rb, Rc, Rd, Re, Rf and Rg, which may be the same or different, each represent hydrogen, amino, hydroxy, alkoxy, alkenyloxy, halogen, acyl, alkenyl, alkyl, or alkoxy substituted by phenyl, Rh is hydrogen, alkyl or --COOH. X is a hydrocarbon chain containing from 2 to 10 carbon atoms and optionally substituted by a hydroxy group, A has no significance or represents Y, OY, or SY and Y represents a C 1 to 4 hydrocarbon chain which is optionally substituted by alkyl C 1 to 4, E and G, which may be the same or different, each represent --O--, --S-- or --CH.sub.2 --, provided that at least one of E and G is --O-- or --S--, L, together with the carbon atoms to which it is attached, forms a benzene, furan, thiophene, pyrrole, or pyran-2-one ring, and pharmaceutically acceptable derivatives thereof.
    描述了具有以下化学式的化合物I,其中Ra、Rb、Rc、Rd、Re、Rf和Rg,可以相同也可以不同,每个代表氢、基、羟基、烷氧基、烯基氧基、卤素、酰基、烯基、烷基或被苯基取代的烷氧基,Rh代表氢、烷基或--COOH。X是一个含有2到10个碳原子的碳氢链,可以选择性地被一个羟基取代,A没有意义或代表Y、OY或SY,Y代表一个C1到4的碳氢链,可以选择性地被烷基C1到4取代,E和G,可以相同也可以不同,每个代表--O--、--S--或--CH2--,但至少其中之一是--O--或--S--,L与其连接的碳原子一起形成苯、呋喃噻吩吡咯喃-2-酮环,并且其药用接受的衍生物
  • Naphthalene and 2-oxo-benzopyran acids and derivatives and
    申请人:Fisons plc
    公开号:US04518612A1
    公开(公告)日:1985-05-21
    There are described compounds of formula I, ##STR1## in which Ra, Rb, Rc, Rd, Re, Rf and Rg, which may be the same or different, each represent hydrogen, amino, hydroxy, alkoxy, alkenyloxy, halogen, acyl, alkenyl, alkyl, or alkoxy substituted by phenyl, Rh is hydrogen, alkyl or --COOH. X is a hydrocarbon chain containing from 2 to 10 carbon atoms and optionally substituted by a hydroxy group, A has no significance or represents Y, OY, or SY and Y represents a C 1 to 4 hydrocarbon chain which is optionally substituted by alkyl C 1 to 4, E and G, which may be the same or different, each represent --O--, --S-- or --CH.sub.2 --, provided that at least one of E and G is --O-- or --S--, L, together with the carbon atoms to which it is attached, forms a benzene, furan, thiophene, pyrrole, or pyran-2-one ring, and pharmaceutically acceptable derivatives thereof.
    公式I中描述了化合物,##STR1## 其中Ra、Rb、Rc、Rd、Re、Rf和Rg可以相同或不同,分别表示氢、基、羟基、烷氧基、烯基氧基、卤素、酰基、烯基、烷基或苯基取代的烷氧基,Rh表示氢、烷基或--COOH。X是一个含有2至10个碳原子的碳氢链,可以选择地被一个羟基取代,A没有意义或表示Y、OY或SY,Y表示一个C1至4的碳氢链,可以选择地被烷基C1至4取代,E和G可以相同或不同,分别表示--O--、--S--或--CH.sub.2--,但至少有一个是--O--或--S--,L与其附着的碳原子一起形成苯、呋喃噻吩吡咯喃-2-酮环,并且其药学上可接受的衍生物
  • Methods of treating alzheimer's disease
    申请人:Nieman A. James
    公开号:US20060079533A1
    公开(公告)日:2006-04-13
    Disclosed are methods for treating Alzheimer's disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of 3,4-disubstituted piperidinyl compounds of formula (I) wherein the variables R 1 , R 2 , R 3 , R 4 , Q, W, X, Z, m, and n are defined herein.
    本发明公开了一种治疗阿尔茨海默病和其他疾病、抑制β-分泌酶酶和/或抑制哺乳动物中A beta肽沉积的方法,使用式(I)的3,4-二取代哌啶基化合物,其中变量R1、R2、R3、R4、Q、W、X、Z、m和n在此定义。
  • Indium-Mediated Regio- and Chemoselective Synthesis of α-Hydroxyalkyl Allenic Esters and Gold-Catalyzed Cyclizations to Ethyl 2-Naphthoate Derivatives
    作者:Chansoo Park、Phil Ho Lee
    DOI:10.1021/ol801196g
    日期:2008.8.7
    The regio- and chemoselective synthetic method of functionalized alpha-hydroxyalkyl allenic esters was developed from the reactions of various aldehydes with organoindium reagent generated in situ from indium and ethyl 4-bromobutynoate. The alpha-hydroxyalkyl allenic esters possessing electron-donating groups were cyclized to ethyl 2-naphthoate derivatives through intramolecular C-alkylation catalyzed by gold salts.
查看更多